Eosinophilic esophagitis (EoE) is a painful allergic disorder of the throat that affects a growing number of children and adults. There is no cure, and few treatments available, none of which are approved by the FDA. Doctors are seeking new ways to help people with EoE.
A new study of the drug reslizumab found that it lowered eosinophil counts but did not improve symptoms. These results are disappointing, but researchers are hopeful that longer-term use of the drug can actually improve symptoms and quality of life for people with EoE. The study only followed participants for 15 weeks, and many of them have stayed on the medication in hopes of future results.